Clinical Research Directory

Value of Analysing Under-utilised Leftover Tissue (VauLT)

Sponsor: Royal Marsden NHS Foundation Trust

Summary

Intratumour heterogeneity is well recognized in multiple cancer types and ultimately leads to therapeutic resistance. It also limits the ability of small samples to represent the whole tumour, having implications for diagnosis, molecular analysis and understanding of the tumour immune microenvironment. By blending- 'homogenizing'- leftover tumour tissue in excess of that required for diagnosistic purposes, one may create a more representative sample for analysis.

Key Details

Conditions

Interventions

Locations (1)